Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea [J]
No medication comes without challenges
While these gastrointestinal effects are dose-dependent and typically occur during initial treatment or dose escalation, most patients find symptoms diminish over time
The bacterial growth in the vial is prevented by the preservative
Bright characters make it easy to read the grid at a glance, and crisp sound cues signal when charge thresholds are near
This comprehensive database systematically collects and analyzes spontaneous reports of adverse drug events and medication errors, enabling the identification and evaluation of potential drug safety signals
